Stanford Blocks 15-PGDH to Regrow Cartilage in Mice, Cutting Arthritis Risk by Half
Updated
Updated · ScienceDaily · Jun 12
Stanford Blocks 15-PGDH to Regrow Cartilage in Mice, Cutting Arthritis Risk by Half
2 articles · Updated · ScienceDaily · Jun 12
Summary
Old mice given a 15-PGDH inhibitor regrew lost knee cartilage, and injured mice treated twice weekly for four weeks were far less likely to develop osteoarthritis.
15-PGDH levels roughly doubled with age in mouse cartilage; blocking the protein preserved prostaglandin E2 and shifted chondrocytes back toward a younger, hyaline-cartilage-producing state.
Cell profiles showed cartilage-degrading chondrocytes fell from 8% to 3%, fibrocartilage-linked cells from 16% to 8%, while hyaline-cartilage-building cells rose from 22% to 42%.
Human cartilage removed during knee replacements also responded after one week of treatment, showing less breakdown activity and new articular cartilage formation.
The finding targets a disease affecting about 1 in 5 U.S. adults and costing roughly $65 billion a year; a related oral inhibitor has already cleared Phase 1 safety testing for muscle weakness.
This arthritis breakthrough seems miraculous, but what are the hidden risks of blocking a natural aging process?
By reversing aging in cartilage, have scientists found a key to regenerating other worn-out body parts?
Could a new pill make knee replacement surgery obsolete within just a few years?
Regenerating Cartilage and Preventing Osteoarthritis: The 15-PGDH Inhibitor Breakthrough and Its Transformative Potential
Overview
In June 2026, Stanford Medicine researchers announced a major breakthrough in osteoarthritis treatment by targeting the aging-related enzyme 15-PGDH. Their novel approach uses a gerozyme inhibitor to block 15-PGDH activity, which plays a critical role in cartilage degradation made worse by aging and joint injuries. This strategy not only prevents arthritis but also regenerates lost cartilage, directly addressing the root cause of the disease. By focusing on the underlying biological process, this discovery offers new hope for millions affected by osteoarthritis, moving beyond symptom relief to true tissue repair.